This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Before investing in crypto, it's crucial to understand the market dynamics and risks involved. Equip yourself with knowledge for better decisions.
20,480 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
When headlines about world diplomacy hit the news, your wallet should not miss the memo. This article breaks down how...
Anthropic's IPO is on the horizon, stirring excitement and questions for investors. This guide breaks down what to wa...
As IPO activity spikes, investors wonder if history is rhyming with 1929 and 2000. This guide breaks down the signals...
When a company’s founder or CEO sells a chunk of stock, it sparks questions. This article breaks down the Zoom inside...
Lucid represents a high-risk, high-reward bet in the EV space. Before you consider investing, these three practical f...
SpaceX captured attention with its IPO buzz, but jumping in right away can backfire. This guide explains why waiting ...
Planning for downturns is not optional—it's essential. This guide shows you how to recession-proof your retirement be...
Looking to ride a big move in a small-cap space? Learn how to spot a small-cap growth stock before it hits its next e...
As an upcoming investor update looms, you may wonder if you should microsoft stock be before the news. This guide bre...
XRP traders are watching a narrow price corridor as Ripple eyes a breakout. With critical support near $1.30 and resi...